Part Number : NDC49669-1310-05 | Manufacturer : Alpha Therapeutic Corp | ||
NSN : 6505-01-234-8934 (6505012348934) | |||
Item Name : Fat Emulsion Injection | CAGE Code : 66159 | ||
NIIN : 01-234-8934 (012348934) | |||
INC Code : 35184 | |||
NCB Code : 01 | Country : USA | ||
Alternate P/N: NDC49669131005 |
Thank you for taking an interest in part number NDC49669-1310-05, that of which is listed with the description Fat Emulsion Injection; Manufactured by Alpha Therapeutic Corp and listed alongside the NSN 6505012348934, part number NDC49669-1310-05 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
Part Number : NDC49669-1310-05 | Manufacturer : Alpha Therapeutic Corp | ||
NSN Number : 6505-01-234-8934 (6505012348934) | |||
Item Name : Fat Emulsion Injection | CAGE Code : 66159 | ||
NIIN : 012348934 |
Thank you for taking an interest in part number NDC49669-1310-05, that of which is listed with the description Fat Emulsion Injection; Manufactured by Alpha Therapeutic Corp and listed alongside the NSN 6505012348934, part number NDC49669-1310-05 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
6505-01-234-8934 Item PartTypeName: FAT EMULSION INJECTION | 6505 | 012348934 | P | |||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
A | ||||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
NDC49669-1310-05 | 5 | 9 | 3 |
MRC | Criteria | Characteristic |
---|---|---|
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.210 PERCENTAGE,V/V GLYCERIN ACTIVE INGREDIENT AND 10.000 PERCENTAGE,V/V SOYBEAN OIL ACTIVE INGREDIENT AND 1.20 PERCENTAGE,W/V EGG PHOSPHATIDES ACTIVE INGREDIENT |
CQCT | PRIMARY CONTAINER TYPE | PACKAGE |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 500.000 MILLILITERS |
CSGS | ADMINISTRATION | INTRAVENOUS |
FEAT | SPECIAL FEATURES | WITH INTRAVENOUS INJECTION SET |
We hope that you will visit us again the next time you need board-level components, aviation and aerospace parts, and more. Allow us to serve as your strategic purchasing partner.
Request for Quote